Axcelis Technologies (ACLS) Lifted to “Sell” at ValuEngine

Share on StockTwits

ValuEngine upgraded shares of Axcelis Technologies (NASDAQ:ACLS) from a strong sell rating to a sell rating in a research note issued to investors on Wednesday morning.

Other equities research analysts have also issued reports about the stock. Needham & Company LLC restated a buy rating and set a $27.00 target price on shares of Axcelis Technologies in a research report on Friday, August 3rd. Craig Hallum upgraded shares of Axcelis Technologies from a hold rating to a buy rating in a research report on Friday, August 3rd. Benchmark reiterated a buy rating and issued a $32.00 price objective on shares of Axcelis Technologies in a research report on Friday, August 3rd. BidaskClub upgraded shares of Axcelis Technologies from a sell rating to a hold rating in a research report on Tuesday, July 10th. Finally, B. Riley lowered shares of Axcelis Technologies from a buy rating to a neutral rating and decreased their price objective for the stock from $34.00 to $20.00 in a research report on Monday, October 29th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and four have assigned a buy rating to the company’s stock. Axcelis Technologies has a consensus rating of Hold and an average target price of $27.00.

Shares of NASDAQ ACLS traded down $0.58 during trading on Wednesday, hitting $17.05. 139,120 shares of the company were exchanged, compared to its average volume of 306,136. The firm has a market capitalization of $576.29 million, a P/E ratio of 11.52 and a beta of 0.97. Axcelis Technologies has a 1 year low of $15.72 and a 1 year high of $37.05.

Axcelis Technologies (NASDAQ:ACLS) last issued its earnings results on Thursday, November 1st. The semiconductor company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. The company had revenue of $95.40 million for the quarter, compared to analyst estimates of $97.82 million. Axcelis Technologies had a net margin of 28.48% and a return on equity of 13.86%. The business’s revenue was down 8.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.35 EPS. As a group, equities research analysts forecast that Axcelis Technologies will post 1.3 earnings per share for the current year.

Institutional investors have recently added to or reduced their stakes in the stock. Piedmont Investment Advisors LLC purchased a new stake in shares of Axcelis Technologies in the 2nd quarter worth about $148,000. Bank of Montreal Can purchased a new stake in shares of Axcelis Technologies in the 2nd quarter worth about $161,000. Metropolitan Life Insurance Co. NY boosted its position in shares of Axcelis Technologies by 362.2% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 10,363 shares of the semiconductor company’s stock worth $205,000 after buying an additional 8,121 shares in the last quarter. LSV Asset Management purchased a new stake in shares of Axcelis Technologies in the 2nd quarter worth about $209,000. Finally, Eqis Capital Management Inc. purchased a new stake in shares of Axcelis Technologies in the 2nd quarter worth about $225,000. Institutional investors and hedge funds own 84.77% of the company’s stock.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.

Recommended Story: What is a Reverse Stock Split?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Axcelis Technologies (NASDAQ:ACLS)

Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply